Cargando…
外周血炎症指标作为预测性指标在晚期非小细胞肺癌免疫治疗中的应用
BACKGROUND AND OBJECTIVE: Lung cancer is the leading cause of cancer-related death, of which non-small cell lung cancer (NSCLC) is the most common type. Immune checkpoint inhibitors (ICIs) have now become one of the main treatments for advanced NSCLC. This paper retrospectively investigated the effe...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503984/ https://www.ncbi.nlm.nih.gov/pubmed/34521188 http://dx.doi.org/10.3779/j.issn.1009-3419.2021.103.10 |
Ejemplares similares
-
小细胞肺癌免疫治疗疗效预测指标的现状与未来
Publicado: (2020) -
外周血检测指标联合TCF1(+)CD8(+) T淋巴细胞占比预测中晚期肺癌免疫治疗疗效及预后的临床队列研究
por: LUO, Hong, et al.
Publicado: (2023) -
双免疫联合治疗在晚期非小细胞肺癌中的一线应用
Publicado: (2022) -
非小细胞肺癌切除组织中常用免疫组织化学指标尚不能预测远期生存
Publicado: (2016) -
LIPI及iSEND免疫评分在晚期非小细胞肺癌免疫治疗中的预测价值分析
Publicado: (2022)